Equities
Health CareMedical Equipment and Services
  • Price (USD)361.36
  • Today's Change-2.59 / -0.71%
  • Shares traded1.00
  • 1 Year change+23.24%
  • Beta0.9184
Data delayed at least 15 minutes, as of Sep 19 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Stryker Corporation (Stryker) is a medical technology company. It offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. It operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products. It also develops neurointerventional devices for the treatment of intracranial aneurysms. It offers Fortress, a modular wall system for hospitals and ambulatory surgery centers. It specializes in soft tissue fixation products and delivering AI-assisted virtual care workflows.

  • Revenue in USD (TTM)21.39bn
  • Net income in USD3.45bn
  • Incorporated1946
  • Employees52.00k
  • Location
    Stryker Corp1941 STRYKER WAYPORTAGE 49002United StatesUSA
  • Phone+1 (269) 385-2600
  • Fax+1 (269) 385-1062
  • Websitehttps://www.stryker.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SYK:NYQ since
announced
Transaction
value
Serf SASDeal completed18 Dec 202318 Dec 2023Deal completed24.54%--
Data delayed at least 15 minutes, as of Sep 19 2024 00:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medtronic PLC32.58bn3.93bn113.03bn95.00k29.642.3617.153.472.972.9724.6637.390.36092.035.51342,915.804.384.574.925.1465.5366.7512.1413.491.6112.100.366580.583.641.16-2.18-4.566.956.65
Boston Scientific Corporation15.23bn1.83bn121.59bn48.00k66.765.9639.837.981.241.2410.2913.850.43071.946.72317,250.005.162.506.072.9169.0868.8411.986.471.145.730.3390.0012.297.71144.55-0.42767.82--
Stryker Corp21.39bn3.45bn137.68bn52.00k40.306.9730.756.448.978.9755.6251.860.55891.606.22411,326.909.016.6010.947.8464.0563.9916.1213.130.9531--0.382143.7011.118.5534.229.680.104710.16
Intuitive Surgical, Inc.7.57bn2.09bn171.00bn13.68k82.7811.6565.8222.585.825.8221.0641.400.49572.107.52553,707.3013.8112.4215.4213.8366.8667.6027.8626.314.22--0.000.0014.4913.8535.989.7741.53--
Danaher Corp23.57bn4.06bn196.37bn61.00k50.003.9531.328.335.445.6331.6368.920.28843.296.23386,360.704.965.935.476.5659.1658.7917.2119.111.0417.190.254214.33-10.336.98-32.5011.8516.1011.32
Abbott Laboratories40.73bn5.56bn199.88bn114.00k36.155.0822.704.913.183.1823.2922.600.55652.656.25357,236.807.597.729.449.3955.4356.7313.6514.391.1825.440.271654.95-8.125.58-17.4518.369.5712.74
Data as of Sep 19 2024. Currency figures normalised to Stryker Corp's reporting currency: US Dollar USD

Institutional shareholders

34.94%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 202430.55m8.02%
Greenleaf Asset Management, Inc.as of 06 Aug 202421.05m5.52%
BlackRock Fund Advisorsas of 30 Jun 202417.12m4.49%
SSgA Funds Management, Inc.as of 30 Jun 202414.27m3.74%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 202411.21m2.94%
Wellington Management Co. LLPas of 30 Jun 202410.99m2.88%
Capital Research & Management Co. (Global Investors)as of 30 Jun 20247.33m1.92%
Fundsmith LLPas of 30 Jun 20247.24m1.90%
Geode Capital Management LLCas of 30 Jun 20246.74m1.77%
JPMorgan Investment Management, Inc.as of 30 Jun 20246.65m1.75%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.